Lactiga
Business Services · United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.lactiga.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About Lactiga
Lactiga is an award-winning, venture-backed biotechnology company focused on developing innovative mucosal antibody therapies to advance immunoscience. They are pioneering the use of secretory IgA antibodies derived from human milk to enhance mucosal immunity and transform treatment for various conditions, including chronic respiratory disorders and immune deficiencies. Their groundbreaking approach aims to shift therapeutic antibody development from systemic to mucosal delivery, targeting the point of entry for pathogens. Lactiga's mission is to improve the quality of life for vulnerable populations by creating more effective therapies that prevent infections.Explore more
Lactiga Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Lactiga your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Lactiga is spiking on competitors!
Check if Lactiga has recently received funding, and reach out quickly before it becomes old news!
Click to see if Lactiga had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Lactiga recently announced quarterly report
Product Launch: Get notified when Lactiga launches new products
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Lactiga has new funding data
Congratulate Masked Content for being promoted to Masked Content at Lactiga
Lactiga, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Lactiga
Compare insights from companies similar to Lactiga, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Lactiga is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Lactiga is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Lactiga.
Lactiga financials insights
Gather financial insights about Lactiga, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Angel/Seed
$1.6M
Lactiga Tech Stack
A closer look at the technologies used by Lactiga
See more technologies
Most Recent Scoops
Partnership
Project
Partnership, Product Development, Business Development, Medical Research, Pharmaceuticals, Healthcare Technology
Funding
Funding
Funding
Funding
Lactiga News & Media
Kenox Pharmaceuticals Announces Strategic Collaboration with Lactiga to Advance Mucosal-Targeted Immunotherapy
PRINCETON, N.J., March 10, 2025 /PRNewswire/ -- Kenox Pharmaceuticals Inc. and Lactiga US, Inc. are pleased to announce a strategic collaboration to advance the development of novel, groundbreaking, mucosal-targeted Secretory IgA (sIgA) therapies for immunodeficient patients. This...Lactiga Secures Multi-Year, Multi-Million Dollar Grant from NIH's National Institute of Allergy ...
Lactiga, a biotech company leading the development of naturally-occurring antibody therapies for inflammatory and immunodeficient conditions, has beenLactiga Secures Multi-Year, Multi-Million Dollar Grant from NIH’s National Institute of Allergy and Infectious Diseases to Advance Groundbreaking, Mucosal-Targeted Secretory IgA for Immunodeficient Patients
NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)--Lactiga, a biotech company leading the development of naturally-occurring antibody therapies for inflammatory and immunodeficient conditions, has been awarded a highly competitive multi-year, multi-million dollar grant from the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID). This funding will accelerate the advancement of Lactiga’s lead asset, LCTG-001—the first-ever secretory IgA (sIgA) mucosally-targetLactiga Receives FDA 'Rare Pediatric Disease' Designation for Groundbreaking Mucosal Immunoglobulin Therapy for Common Variable Immunodeficiency Disease
LCTG-001 on course to be the first FDA-approved biologic from human milk
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Lactiga
Sign Up For FreeTo access detailed company insights
Lactiga is an award-winning, venture-backed biotechnology company focused on developing innovative mucosal antibody therapies to advance immunoscience. They are pioneering the use of secretory IgA antibodies derived from human milk to enhance mucosal immunity and transform treatment for various conditions, including chronic respiratory disorders an... Read More
